These results are in line with our observation that RB94 was cytotoxic to multiple NSCLC types irrespective of their genetic makeup (i.e., RB status), suggesting that SGT-94 could be expanded to other tumor types irrespective of their native RB status [19]. The gene discussed is RB1; the disease is non-small cell lung carcinoma.